Skip to main content
. Author manuscript; available in PMC: 2007 Jun 1.
Published in final edited form as: Vaccine. 2007 Jan 10;25(17):3437–3444. doi: 10.1016/j.vaccine.2006.12.045

Figure 6.

Figure 6

Percent Survival in Therapeutically Treated Mice. Survival was monitored for 103 days in groups of five mice therapeutically treated with the E7IR construct. At 103 days post TC-1 challenge, 60% of E7IR mice survived compared to 0% of naïve or E7WT vaccinated mice. Data is representative of two experiments.